[1]
Schlösser, A.R. et al. 2025. Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study. Acta Dermato-Venereologica. 105, (Nov. 2025), adv44165. DOI:https://doi.org/10.2340/actadv.v105.44165.